Skip to main content
. Author manuscript; available in PMC: 2022 Jan 1.
Published in final edited form as: Obesity (Silver Spring). 2020 Nov 22;29(1):56–61. doi: 10.1002/oby.23010

Figure 2.

Figure 2.

Response time in go trials (go RT) and percentage of erroneous responses in stop trials (stop error) following intranasal oxytocin and placebo administration for each individual (N=10). The observed overall pattern of increased go RTs combined with fewer stop errors is consistently present in eight out of ten individuals, suggesting that the reported finding reflects a general effect of oxytocin.